COVIran Barekat

From Simple English Wikipedia, the free encyclopedia
COVIran Barekat
A vial of COVIran Barakat
Vaccine description
Target diseaseSARS-CoV-2
Clinical data
کووایران برکت
Routes of
ATC code
  • None
Legal status
Legal status
  • Emergency use authorization: IRN
Full and Emergency Authorizations: List of COVIran Barekat COVID-19 vaccine authorizations

COVIran Barekat[1] is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, part of the Barkat Pharmaceutical Group.[2][3][4] It is an inactivated virus-based vaccine.[1] Iranian authorities authorized its emergency use. It is the first locally developed COVID-19 vaccine to be approved for emergency use in the Middle East.[5]

References[change | change source]

  1. 1.0 1.1 Mallapaty S (August 2021). "Iran hopes to defeat COVID with home-grown crop of vaccines". Nature. 596 (7873): 475. Bibcode:2021Natur.596..475M. doi:10.1038/d41586-021-02216-z. PMID 34404947. S2CID 237198729.
  2. Motamedi M (29 December 2020). "COVIran Barakat: Iran launches human trials of its COVID vaccine". Al Jazeera. Archived from the original on 31 January 2021.
  3. "Iran's leader gets locally made coronavirus vaccine shot". Reuters. 2021-06-25. Retrieved 2021-08-24.
  4. "About - شرکت گروه صنایع شفافارمد". 2021-04-15. Retrieved 2021-09-03.
  5. Baghishov E (14 June 2021). "Iran issues license on its coronavirus vaccine". Trend.Az. Archived from the original on 2021-06-14. Retrieved 14 June 2021.